All posts in
Novartis puts the Development of two Anti-Aging Drugs in American Hands
Rethinking Profits: Can a Socially Conscious Model work in Biotech?
Will BMS Take Over a Danish Biotech in a Massive €500M Deal?
MedTech Company Launches Large €55M IPO for Artificial Heart Valves
Can this British Biotech Overcome Failure buying drugs from AstraZeneca?
UK Immunotherapy Biotech raises Massive Funding in Series C
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
Huge Successful €103M IPO for the Next European Leader in Bioplastics
A Norwegian Immuno-Oncology Biotech is preparing for an IPO
Which European Blockbusters Topped the Charts in 2016?
German Biotech closes Largest Series A Fundraising of 2017 So Far
UPDATE: Reproductive Health Biotech starts Phase III after €90M IPO
Labiotech UG, All Rights Reserved -
Send this to friend